CRL

查尔斯河实验室国际
NYSE

实时行情|Nasdaq Last Sale

126.23
-3.78
-2.91%
盘后: 126.23 0 0.00% 16:09 03/27 EDT
开盘
130.00
昨收
130.01
最高
130.00
最低
121.39
成交量
53.83万
成交额
--
52周最高
179.38
52周最低
95.58
市值
61.80亿
市盈率(TTM)
24.90
分时
5日
1月
3月
1年
5年

分析师评级

18位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CRL价格均价为174.60,最高价位204.00,最低价为124.00。

EPS

CRL 新闻

更多
  • Stifel likes bluebird bio in premarket analyst action
  • Seeking Alpha - Article · 1天前
  • How Does Charles River Laboratories International's (NYSE:CRL) P/E Compare To Its Industry, After The Share Price Drop?
  • Simply Wall St. · 3天前
  • Is Charles River Laboratories International Inc. (CRL) Relatively A Good Stock To Buy?
  • Insider Monkey · 6天前
  • SunTrust Robinson Humphrey Maintains Buy on Charles River, Lowers Price Target to $124
  • Benzinga · 03/17 16:07

所属板块

生物技术和医学研究
-2.43%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

CRL 简况

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.
展开

微牛提供Charles River Laboratories Intl. Inc(NYSE-CRL)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CRL股票新闻,以帮助您做出投资决策。